Analyses of variant human papillomavirus type-16 E5 proteins for their ability to induce mitogenesis of murine fibroblasts

Cancer Cell International

Volumn 6, Issue , 2006, Pages

  Nath, Rahul ^a   Mant, Christine A ^a   Kell, Barbara ^a   Cason, John ^a   Bible, Jon M ^a  

^a GUY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LEUCINE; PROTEIN E5; PROTEIN P21; THREONINE; UNCLASSIFIED DRUG; VALINE; VIRUS PROTEIN;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CELL CYCLE PROGRESSION; CELL GROWTH; CONTROLLED STUDY; FIBROBLAST; HUMAN PAPILLOMAVIRUS TYPE 16; MITOGENESIS; MITOSIS; MOUSE; MOUSE STRAIN; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; PROTEIN VARIANT; UNITED KINGDOM; VIRUS STRAIN;

EID: 33748952337     PISSN: 14752867     EISSN: 14752867     Source Type: Journal    
DOI: 10.1186/1475-2867-6-19     Document Type: Article

References (38)

1. Adam JL, Briggs MW, McCance DJ: A mutagenic analysis of the E5 protein of human papillomavirus type 16 reveals that E5 binding to the vacuolar H+-ATPase is not sufficient for biological activity, using mammalian and yeast expression systems. Virology 2000. 272:315-325.
2. Rodriguez MI, Finbow ME, Alonso A: Binding of human papillomavirus 16 E5 to the 16 kDa subunit c (proteolipid) of the vacuolar H+-ATPase can be dissociated from the E5-mediated epidermal growth factor receptor overactivation. Oncogene 2000, 19:3727-3732.
3. Stoler MH, Rhodes CR, Whitbeck A, Wolinsky SM, Chow LT, Broker TR: Human papillomavirus type 16 and 18 gene expression in cervical neoplasias. Human Pathol 1992, 23:117-127.
4. Kell B, Jewers RJ, Cason J, Pakarian F, Kaye JN, Best JM: Detection of E5 oncoprotein in human papillomavirus type 16-positive cervical scrapes using antibodies raised to synthetic peptides. J Gen Virol 1994, 75:2451-2456.
5. Biswas C, Kell B, Mant C, Jewers RJ, Cason J, Muir P, Raju KS, Best JM: Detection of human papillomavirus type 16 early-gene transcription by reverse transcription-PCR is associated with abnormal cervical cytology. J Clin Microbiol 1997, 35:1560-1564.
6. Hsieh CH, Tsao YP, Wang CH, Han CP, Chang JL, Lee JY, Chen SL: Sequence variants and functional analysis of human papillomavirus type 16 E5 gene in clinical specimens. Arch Virol 2000, 145:2273-2284.
7. Conrad M, Bubb VJ, Schlegel R: The human papillomavirus type 6 and 16 E5 proteins are membrane-associated proteins which associate with the 16-kilodalton pore-forming protein. J Virol 1993, 67:6170-6178.
8. Conrad M, Goldstein D, Andersson T, Schlegel R: The E5 protein of HPV-6, but not HPV-16, associates efficiently with cellular growth factor receptors. Virology 1994, 200:796-800.
9. Hwang ES, Nottoli T, DiMaio D: The HPV 16 E5 protein: expression, detection, and stable complex formation with transmembrane proteins in COS cells. Virology 1995, 211:227-233.
10. Straight SW, Hinkle PM, Jewers RJ, McCance DJ: The ES oncoprotein of human papillomavirus type 16 transforms fibroblasts and effects the downregulation of the epidermal growth factor receptor in keratinocytes. J Virol 1993, 67:4521-4532.
11. Straight SW, Herman B, McCance DJ: The E5 oncoprotein of human papillomavirus type 16 inhibits the acidification of endosomes in human keratinocytes. J Virol 1995, 69:3185-3192.
12. Ashby AD, Meagher L, Campo MS, Finbow ME: E5 transforming proteins of papillomaviruses do not disturb the activity of the vacuolar H (+)-ATPase. J Gen Virol 2001, 82:2353-2362.
13. Thomsen P, van Deurs B, Norrild B, Kayser BL: The HPV16 E5 oncogene inhibits endocytic trafficking. Oncogene 2000, 19:6023-6032.
14. Ahn NG, Seger R, Bratlien RL, Dieltz CD, Tonks NK, Krebs EG: Multiple components in an epidermal growth factor-stimulated protein kinase cascade. In vitro activation of a myelin basic protein/microtubule-associated protein 2 kinase. J Biol Chem 1991, 266:4220-4227.
15. Crews CM, Alessandrini A, Erikson RL: The primary structure of MEK, a protein kinase that phosphorylates the ERK gene product. Science 1992, 258:478-480.
16. Gardner AM, Vaillancourt RR, Johnson GL: Activation of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase by G protein and tyrosine kinase oncoproteins. J Biol Chem 1993, 268:17896-17901.
17. Alessi DR, Saito Y, Campbell DG, Cohen P, Sithanandam G, Rapp U, Ashworth A, Marshall CJ, Cowley S: Identification of the sites in MAP kinase kinase-1 phosphorylated by p74raf-1. EMBO J 1994, 7:1610-1619.
18. Leptak C, Ramon Y, Cajal S, Kulke R, Horwitz BH, Riese DJ II, Dotto GP, DiMaio D: Tumorigenic transformation of murine keratinocytes by the E5 genes of bovine papillomavirus type 1 and human papillomavirus type 16. J Virol 1991, 65:7078-7083.
19. Leechanachai P, Banks L, Moreau LF, Matlashewski G: The E5 gene from human papillomavirus type 16 is an oncogene which enhances growth factor-mediated signal transduction to the nucleus. Oncogene 1992, 7:19-25.
20. Pim D, Collins M, Banks L: Human papillomavirus type 16 E5 gene stimulates the transforming activity of the epidermal growth factor receptor. Oncogene 1992, 7:27-32.
21. Chen SL, Tsao YP, Yang CM, Lin YK, Huang CH, Kuo SW: Differential induction and regulation of c-jun, junB, junD and c-fos by human papillomavirus type 11 E5a oncoprotein. J Gen Virol 1995, 76:2653-2659.
22. Chen SL, Lin YK, Li L-Y, Tsao Y-P, Lo H-Y, Wang W-B, Tsai T-C: E5 proteins of human papillomavirus types 11 and 16 transactivate the c-fos promoter through the NF1 binding element. J Virol 1996, 70:8558-8563.
23. Chen SL, Huang CH, Tsai TC, Lu KY, Tsao Y-P: The regulation mechanism of c-jun and junB by human papillomavirus type 16 E5 oncoprotein. Arch Virol 1996, 141:791-800.
24. Bible JM, Mant C, Best JM, Kell B, Starkey WG, Raju KS, Biswas C, Muir P, Banatvala JE, Cason J: Cervical lesions are associated with human papillomavirus type 16 intratypic variants that have high transcriptional activity and increased usage of common mammalian codons. J Gen Virol 2000, 81:1517-1527.
25. Seedorf K, Kraemmer G, Duerst M, Suhai S, Rowekamp WG: Human papillomavirus type 16 DNA sequence. Virology 1985, 145:181-185.
26. Halbert CL, Galloway DA: Identification of the E5 open reading frame of human papillomavirus type 16. J Virol 1988, 62:1071-1075.
27. Gilchrist R, Lomax ME, Camplejohn RS: The need for dynamic methods for measuring cell cycle perturbations: a study in radiation-treated lymphoblastoid cell lines of varying p53 status. Cell Prolif 1999, 32:15-24.
28. Quinn CM, Wright NA: The clinical assessment of proliferation and growth in human tumours: evaluation of methods and applications as prognostic variables. J Pathol 1990, 160:93.
29. Tsao YP, Li LY, Tsai TC, Chen SL: Human papillomavirus type 11 and 16 E5 represses p21 (Waf1/Sdi1/Cip1) gene expression in fibroblasts and keratinocytes. J Virol 1996, 70:7535-7539.
30. Kozak M: At least six nucleotides preceding the AUG initiator codon enhance translation in mammalian cells. J Mol Biol 1987, 196:947-950.
31. Ndisang D, Faulkes DJ, Gascoyne D, Lee SA, Ripley BJ, Sindos M, Singer A, Budhram-Mahadeo V, Cason J, Latchman DS: Differential regulation of different human papilloma virus variants by the POU family transcription factor Brn-3a. Oncogene 2006, 25:51-60.
32. Lehninger AL: Biochemistry, the molecular basis of cell structure and function. Pub: Worth Inc, N.Y; 1975:130.
33. [http://pref.etos.hr/split/].
34. Ullman CG, Haris PI, Kell B, Cason J, Jewers RJ, Best JM, Emery VC, Perkins SJ: Hypothetical structure of the membrane-associated E5 oncoprotein of human papillomavirus type 16. Biochem Soc Transact 1994, 22:439S.
35. Tsao YP, Huang CH, Lin YK, Chen SL: Protein kinase C-and rasdependent activation of c-jun gene by human papillomavirus type 11 E5a oncoprotein. Cancer Lett 1995, 95:201-205.
36. Choi YH, Zhang L, Lee WH, Park KY: Genistein-induced G2/M arrest is associated with the inhibition of cyclin B1 and the induction of p21 in human breast carcinoma cells. Int J Oncol 1998, 13:391-396.
37. McGrath-Morrow SA, Stahl J: Growth arrest in A549 cells during hyperoxic stress is associated with decreased cyclin B1 and increased p21 (Waf1/Cip1/Sdi1) levels. Biochem Biophys Acta 2001, 1538:90-97.
38. Boyse EA, Old LJ, Chououimikou L: Methods in Medical Research. Volume 10. Edited by: Eisen HN. Pub: Chicago Year Book Medical Publishers, Chicago; 1964:39.